Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2005
08/31/2005CN1662501A Cyanoguanidine prodrugs
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662259A Process for producing block copolymer/drug composite
08/31/2005CN1662255A Use of substances for treating tumors
08/31/2005CN1662254A ALCAM and ALCAM modulators
08/31/2005CN1662251A Adjuvant enhanced immunotherapy
08/31/2005CN1662250A Aqueous preparation containing oligopeptides and etherified cyclodextrin
08/31/2005CN1662248A Compositions against inflammatory processes
08/31/2005CN1662245A (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
08/31/2005CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines
08/31/2005CN1662241A Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
08/31/2005CN1662239A Combination comprising a vasculostatic compound and an alkylating agent for the treatmemt of a tumor
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1662234A Use of thio-oxindole derivatives in treatment of hormone-related conditions
08/31/2005CN1662226A Monocompartment osmotic controlled drug delivery system
08/31/2005CN1661110A Novel targets for obesity from fat tissue
08/31/2005CN1661019A Method for producing recombined endothelium chalone in bacillus colis and application
08/31/2005CN1661012A Miniaturized polypeptide of anti EB Virus tumour, application and preparation method
08/31/2005CN1660912A Anti IL-8 monoclonal antibody, sequence of its variable region and application
08/31/2005CN1660911A Connective tissue growth factor fragments and methods and uses thereof
08/31/2005CN1660900A CUDR as biomarker for cancer progression and therapeutic response
08/31/2005CN1660899A GP thymosin alpha 1 and preparation method
08/31/2005CN1660895A Synthesized polypeptide and application
08/31/2005CN1660885A Sulfonated sterol, preparing method and application
08/31/2005CN1660881A New type molecules of immunization stimulus and preparation method
08/31/2005CN1660851A Ramification of water-soluble camptothecin and preparation method
08/31/2005CN1660850A Method for preparing dehydrogenated cavidine, dehydrogenated apocavidine and combination
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660843A Matrine and salt of organic acid of oxidized matrine and its prepn. process
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660836A Compound of dehydrogenated cavidine group and application in medication
08/31/2005CN1660835A Compound of substituted nonane oxide-2-ketone, preparation method and application
08/31/2005CN1660824A 2-substitution-5-(3, 4, 5-trialkoxy phenyl)-1, 3, 4-ramification of thiadiazoles and preparation method and biological activity
08/31/2005CN1660819A Ramification of N-carbethoxy cytosine and preparation method and application
08/31/2005CN1660817A Alkaline amino acid salt of Glycididazole acid, preparation and application
08/31/2005CN1660444A Immunity coupler of containing monoclonal antibody Fab' segment of anti TV type collagenase poly glutamic acid-blemycin A5
08/31/2005CN1660438A Slow released anticancer combination of medication embedded the interior of the body
08/31/2005CN1660437A Combination of slow released anticancer medication
08/31/2005CN1660436A Anticancer combination of medication
08/31/2005CN1660434A Combination of medication for anti malignant tumours and application
08/31/2005CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment
08/31/2005CN1660426A Methods for inhibiting brain tumor growth
08/31/2005CN1660415A Admixture of enkephalin containing methionine and trilobate cinquefoil and application
08/31/2005CN1660414A Stable preparation of interferon
08/31/2005CN1660412A Method of preparing microsphere of ethoxyl copolymer PLGA in interferon poly acid
08/31/2005CN1660407A Liquid preparation containing penta peptide of thymus and preparing method
08/31/2005CN1660402A Combination of Chinese traditional medicine in use for assistant treating cancer and preparation method
08/31/2005CN1660394A Compound preparation of Chinese traditional medicine for anticancer
08/31/2005CN1660393A Health products of anti fatigue, decreasing blood pressure and blood fat, against cancer and cancer preyention, and preparing method
08/31/2005CN1660346A Chinese materia medica preparation for treating tumors and cancer
08/31/2005CN1660338A Technique for preparing 'Shenqi' of freeze drying powder for strengthening the body resistance
08/31/2005CN1660337A Specific medicine for radical curing breast cancer and diversified malignant poisoned sores
08/31/2005CN1660302A Extractive form corm of saffron, preparation method and application
08/31/2005CN1660290A Hematogenesis capsule and preparation method
08/31/2005CN1660262A Method for preparing non-polymerized polyphenolic substance from flowerlet Agrimony
08/31/2005CN1660257A Soft capsule of extractive from leaves of persimmon and self-emulsifying system for releasing drug
08/31/2005CN1660225A Medication of effective part of bee pollen form cole, preparation method and application
08/31/2005CN1660219A Chinese traditional medicine for treating diseases of alimentary canal and preparation method
08/31/2005CN1660184A Combination of medicaiton containing extractive of herb of glabrous sarcandra, and preparation method and application
08/31/2005CN1660180A Chinese traditional medicine for treating leukaemia
08/31/2005CN1660164A Combination for treating leukaemia
08/31/2005CN1660141A Drop pills of arenobufagin and preparation method
08/31/2005CN1660139A Method for preparing oral medication by using extractive from oyster alone
08/31/2005CN1660105A Disintegration piece taken through oral cavity containing Gimeracil and Oteracil Potassium with fluorine being added
08/31/2005CN1660097A Combination of medication for treating cancers and preparation method
08/31/2005CN1660085A Controlled and released preparation of kurarinone detained in stomach
08/31/2005CN1660083A Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
08/31/2005CN1660073A Nano granules of Docetaxel and preparing method
08/31/2005CN1660071A Application of injection of quick dissolving solid in yew alkyl class in preparing medicine for anti transfer of tumor
08/31/2005CN1660070A Slow released combination of anticancer drugs embedded in vivo
08/31/2005CN1660067A Application of liganans of biphenyl cyelo-octadiene in preparing antineoplastic medicine
08/31/2005CN1660061A Compsn.for treating tumours and its use
08/31/2005CN1217190C Modulation of smrl-nep interactions in cns disorders giving rise to mental disorders
08/31/2005CN1216992C Immunomodulators
08/31/2005CN1216913C Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line
08/31/2005CN1216910C Novel liver regeneration related protein, its code sequence and application
08/31/2005CN1216909C Human cervical cancer suppressor protein, polynucleotide encoding the protein cell transformed with the polynucleotide and method
08/31/2005CN1216883C Synthesis of anticancer medicine raltiprexed
08/31/2005CN1216878C Process for poreparing genistein, medicinal composition and use thereof
08/31/2005CN1216869C Polymorphic crystalline forms of celecoxib
08/31/2005CN1216867C 2-amino-nicotinamide derivative sand their use as VEGF-receptor tyrosine kinase inhibitors
08/31/2005CN1216866C Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
08/31/2005CN1216857C Aniline-derived ligands for thyroid receptor
08/31/2005CN1216856C Novel cyclocompound having cycloalkylene chain, prepn. method and pharmaceutical compositions contg. same
08/31/2005CN1216644C Tin-117m-containing radio therapeutic agents
08/31/2005CN1216638C Genes coding proteins for early liver development and their use indiagnosing and treating liver disease
08/31/2005CN1216637C Pharmaceutical composition containing an inhibitor of immunoglobulin-receptor interaction
08/31/2005CN1216636C Titanium slow-release composition
08/31/2005CN1216626C Shenhong capsule with actions of removing blood stasis and obstruction
08/31/2005CN1216620C Composite medicine for treating leukemia
08/31/2005CN1216616C Use of Chinese herb peucedanum praeruptorum in preparation of medicine for treating tumor
08/31/2005CN1216605C Combination therapy for treatment of tumors
08/30/2005US6936715 Lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
08/30/2005US6936714 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof
08/30/2005US6936704 a nucleotide sequence which hybridizes to the complement of the specific nucleic acid molecule over its full length under conditions of incubation and encodes a polypeptide which costimulates T cell proliferation in vitro
08/30/2005US6936700 Radiolabeled chelation compounds used in pharmaceuticals for diagnostic and therapeutic purposes
08/30/2005US6936691 Secreted protein HCE3C63
08/30/2005US6936689 Peptide antagonists of zonulin and methods for use of the same
08/30/2005US6936634 Ruthenium (II) compounds for use in the therapy of cancer
1 ... 1262 1263 1264 1265 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 ... 2211